Author [ Title] Type Year
Filters: Author is Li, Hui [Clear All Filters]
Alterations of proliferation and differentiation of hippocampal cells in prenatally stressed rats. Brain Dev. 2014..
Big Animal Cloning Using Transgenic Induced Pluripotent Stem Cells: A Case Study of Goat Transgenic Induced Pluripotent Stem Cells. Cell Reprogram. 2016;18(1):37-47..
Bone marrow mesenchymal stem cells with Nogo-66 receptor gene silencing for repair of spinal cord injury. Neural Regen Res. 2014;9(8):806-14..
Identification of chimeric RNAs in human infant brains and their implications in neural differentiation. Int J Biochem Cell Biol. 2019.
Immobilization of type I collagen/hyaluronic acid multilayer coating on enoxacin loaded titania nanotubes for improved osteogenesis and osseointegration in ovariectomized rats. Colloids Surf B Biointerfaces. 2018;175:409-420..
The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6. J Neuroinflammation. 2015;12(1):61.
Intra-articular Injection of Cell-laden 3D Microcryogels Empower Low-dose Cell Therapy for Osteoarthritis in a Rat Model. Cell Transplant. 2020;29:963689720932142..
Mesenchymal stem cells derived from induced pluripotent stem cells play a key role in immunomodulation during cardiopulmonary resuscitation. Brain Res. 2019..
Metastatic Phosphatase PRL-3 Induces Ovarian Cancer Stem Cell Sub-population through Phosphatase-Independent Deacetylation Modulations. iScience. 2019;23(1):100766..
MicroRNA Profiling Response to Acupuncture Therapy in Spontaneously Hypertensive Rats. Evid Based Complement Alternat Med. 2015;2015:204367..
MicroRNA-922 Promotes Tau Phosphorylation by Downregulating Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) Expression in the Pathogenesis of Alzheimer's disease. Neuroscience. 2014..
Sensory neuron differentiation potential of in utero mesenchymal stem cell transplantation in rat fetuses with spina bifida aperta. Birth Defects Res A Clin Mol Teratol. 2015.
Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia. Blood. 2013.
Tributyltin reduces bone mineral density by reprograming bone marrow mesenchymal stem cells in rat. Environ Toxicol Pharmacol. 2019;73:103271..